Dian Diagnostics GroupLtd Management
Management criteria checks 2/4
Dian Diagnostics GroupLtd's CEO is Haibin Chen, appointed in May 2010, has a tenure of 15.5 years. directly owns 26.91% of the company’s shares, worth CN¥2.67B. The average tenure of the management team and the board of directors is 3.4 years and 2 years respectively.
Key information
Haibin Chen
Chief executive officer
CN¥3.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.5yrs |
| CEO ownership | 26.9% |
| Management average tenure | 3.4yrs |
| Board average tenure | 2yrs |
Recent management updates
Recent updates
Is Dian Diagnostics GroupLtd (SZSE:300244) A Risky Investment?
Mar 25
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Price Is Right But Growth Is Lacking After Shares Rocket 43%
Feb 10Dian Diagnostics GroupLtd (SZSE:300244) Will Want To Turn Around Its Return Trends
Jan 02Here's Why Dian Diagnostics GroupLtd (SZSE:300244) Can Manage Its Debt Responsibly
Dec 12Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22CEO
Haibin Chen (56 yo)
Mr. Haibin Chen,B.S. (EMBA) serves as Chairman of the Board at Dian Diagnostics Group Co. Ltd since May 2010 and serves as its General Manager since November 3, 2023. He was the Chairman, General Manager a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 15.5yrs | CN¥3.01m | 26.91% CN¥ 2.7b | |
| Deputy GM | 2.3yrs | CN¥2.78m | no data | |
| Deputy General Manager & Director | 6.8yrs | CN¥2.55m | no data | |
| Deputy General Manager & Director | 2yrs | CN¥2.23m | no data | |
| Deputy GM & Secretary of the Board | 4.5yrs | CN¥985.90k | no data | |
| Deputy General Manager | 2yrs | CN¥2.08m | no data |
Experienced Management: 300244's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman of the Board | 15.5yrs | CN¥3.01m | 26.91% CN¥ 2.7b | |
| Deputy GM | 2yrs | CN¥2.78m | no data | |
| Deputy General Manager & Director | 6.2yrs | CN¥2.55m | no data | |
| Deputy General Manager & Director | 2yrs | CN¥2.23m | no data | |
| Non-Independent Director | 2yrs | no data | no data | |
| Independent Director | 5.2yrs | CN¥120.00k | no data | |
| Chairman of the Supervisory Board | 2yrs | no data | no data | |
| Non-Independent Director | 2yrs | no data | no data | |
| Independent Director | 2yrs | CN¥120.00k | no data | |
| Independent Director | 2yrs | no data | no data | |
| Employee Supervisor | 2yrs | no data | no data | |
| Employee Supervisor | 2yrs | no data | no data |
Experienced Board: 300244's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/19 16:03 |
| End of Day Share Price | 2025/11/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dian Diagnostics Group Co.,Ltd. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Jin Zhang | China International Capital Corporation Limited |
| Sophia Zhang | China Stock Investment Research Co. Ltd. (GZ500..com) |